EN
HI
Cohance Lifesciences Chart
Cohance Lifesciences Share Key Metrics
Volume
11.69 L
Market Cap
16073.56 CR
LTQ@LTP
10@420.15
ATP
420.8
Var Margin
100 %
Circuit Range
342.7-514
Delivery %
11.74 %
Value
49.21 CR
ASM/GSM
No
Market Lot
1
Summary
Cohance Lifesciences share price is ₹420.15 as of 20 May, 2026. The stock Cohance Lifesciences intraday movement has stayed between ₹415.15 and ₹428.95, while on a 52-week basis,Cohance Lifesciences price 52 week high is ₹1121.15 & its 52 week low is ₹266.70.
In terms of trading activity, Cohance Lifesciences has recorded a volume of 1169486 shares, The Cohance Lifesciences has a market cap of ₹382567140 CR. The stock’s Average Traded Price (ATP) stands at ₹420.80, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 10 @ ₹420.15.
Cohance Lifesciences operates within a circuit range of ₹342.70 – ₹514.00, with a Value of ₹49.21 CR. The Delivery Percentage for the day is 11.74%. Additionally, Cohance Lifesciences currently falls under the No framework, and trades with a market lot size of 1.
Cohance Lifesciences Fundamentals
View MoreP/E Ratio
91.67
P/B Ratio
4.2
Div. Yield
0
Sector P/E
71.7
Sector P/B
3.51
Sec. Div. Yield
0.56
Cohance Lifesciences Resistance and Support
Pivot 436.97
Resistance
First Resistance
455.39
Second Resistance
482.42
Third Resistance
500.84
Support
First Support
409.94
Second Support
391.52
Third Support
364.49
Cohance Lifesciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-12 | Audited Results |
| 2026-02-12 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
| 2025-05-28 | Audited Results |
| 2025-02-12 | Quarterly Results |
Cohance Lifesciences News
Cohance Lifesciences Limited
Cohance Lifesciences released the transcript of its Q4 & FY26 earnings conference call. The company reported FY26 revenue of INR 22.68 billion, impacted by destocking and inventory adjustments. Management expects recovery to begin from H2 FY27 onwards.
May 15 2026 20:05:00
Cohance Lifesciences Limited
Cohance Lifesciences shareholders to vote on the appointment of Mr. Umang Vohra as Chairman and Group CEO, with an effective date of May 2026. The postal ballot also includes a special resolution for his remuneration, which exceeds prescribed limits, and approval for new Employee Stock Option Plans, including grants potentially exceeding 1% of issued capital.
May 14 2026 20:05:00
Read More
About Cohance Lifesciences
NSE : 17945
BSE : 543064
ISIN : INE03QK01018
Cohance Lifesciences Management
| Name | Position |
|---|---|
| Vivek Sharma | Chairman |
| Umang Vohra | Additional Director |
Cohance Lifesciences Similar Stocks
Natco Pharma Ltd.
1156.30
25.40 (2.25%)
Onesource Specialty Pharma Ltd.
1867.40
12.90 (0.70%)
Astrazeneca Pharma India Ltd.
8609.50
-86.00 (0.99%)
Eris Lifesciences Ltd.
1458.20
122.00 (9.13%)
Granules India Ltd.
758.65
-7.80 (1.02%)
Jubilant Pharmova Ltd.
1014.20
3.25 (0.32%)
Caplin Point Laboratories Ltd.
2016.60
-21.60 (1.06%)
Poly Medicure Ltd.
1459.40
4.30 (0.30%)
Alembic Pharmaceuticals Ltd.
752.35
1.25 (0.17%)
Dr. Agarwal's Health Care Ltd.
459.70
2.85 (0.62%)
Cohance Lifesciences FAQs
The Buying Price of Cohance Lifesciences share is 420.15 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Cohance Lifesciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Cohance Lifesciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Cohance Lifesciences shares is 91.67. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Cohance Lifesciences shares is 4.2. Useful to assess the stock's value relative to its book value.
To assess Cohance Lifesciences’s valuation compare Sector P/E, P/B which are 71.7 & 3.51 with sector averages, along with growth rates and financial metrics.
The Market Cap of Cohance Lifesciences is 16073.56 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Cohance Lifesciences share price is 1121.15 & 266.70. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Cohance Lifesciences belongs to the Healthcare sector.
